Custom workstations and automation-enabled assays will improve reproducibility and productivity
A partnership between life sciences companies Millipore Sigma and Opentrons Labworks will enable the automation of assay kits on a custom Opentrons Flex workstation.
Scientists and engineers will develop and verify platform workflows, automation-enabled assays from Merck, Millipore’s parent company.
“Our customers are prioritising tools and technologies that improve reproducibility and productivity, allowing them to focus on more complex tasks that take their science further, faster,” said Merck head of science and lab solutions Jean-Charles Wirth.
“Our partnership with Opentrons reinforces our focus to automate and digitalise the lab, supporting scientists at all stages with tools that can increase efficiency, safety, and success rates of delivering new potential therapeutics.”
The aim is that the custom workstation and automation-enabled assays will provide consistency and high throughput by minimising manual processing and repetitive tasks with a robotic system.
Applications will include workflows across protein sample preparation, molecular, cell and other biochemical and chemistry workflow launched during the multi-year agreement.
Through a combined effort, the companies will offer products that optimise sample preparation, immunodetection analysis, protein and omics research, enzyme technology, genome editing and pharmaceutical development.
